-
Gov. Ned Lamont has signed legislation allowing free-standing birth centers to operate in Connecticut, starting in 2024. These will serve as an alternative to traditional hospital maternity wards, which in some rural areas of the state are being closed down.
-
Connecticut is suing the owners of Stone Academy, a for-profit nursing school that was quick to close its doors in February after nearly 150 years of operation.The school had offered programs in East Hartford, Waterbury, and West Haven.
-
A recent U.S. Supreme Court decision was a blow to the LGBTQ+ community. In Connecticut, Attorney General William Tong assured the community they will be protected by the state’s anti-discrimination and privacy laws.
-
Connecticut, New York, Massachusetts and 13 other states have filed a brief in the U.S. First Circuit Court of Appeals in support of a Massachusetts school's ability to protect the privacy of transgender students.
-
Connecticut Attorney General William Tong has launched a consumer protection investigation into Hyundai and Kia for failing to install anti-theft devices in their cars.
-
State Attorney General William Tong said Connecticut will get about $16 million from JUUL. The funds will go to behavioral health organizations to curb youth vaping.
-
Connecticut Attorney General William Tong is leading a bipartisan coalition of attorneys general from 39 states who sent a letter to Congress urging the passage of federal legislation to combat the trafficking of illicit xylazine.
-
Connecticut Attorney General William Tong called on the Public Utilities Regulatory Authority to exercise more control over United Illuminating. The power company has proposed rate hikes as high as 8%, and failed to clean environmental toxins from a former power plant in New Haven.
-
The state attorneys general in Connecticut, New York and Massachusetts want the federal government to recall vehicles made by Hyundai and Kia because they're too easy to steal.
-
Connecticut Attorney General William Tong is part of a coalition challenging a ruling that would invalidate FDA approval of the pill.